QRX3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for QRX3, covering 2026-02-18 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF) [Phase 2, Phase 3]